Dr. Katsumi Nakamura of Tobata Kyoritsu Hospital in Japan received first place honors at the 14th annual International Society for Magnetic Resonance in Medicine (ISMRM) meetings for research in non-contrast MRA imaging. Nakamura received the honors for his presentation comparing non-contrast fresh blood imaging (FBI) to 16-slice CT for the diagnosis of peripheral vascular disease using Toshiba’s 1.5 Tesla MRI system.
“Toshiba and its partners have pioneered research into the use of contrast-free MRA for the diagnosis of peripheral vascular disease,” said Bob Giegerich, director, MR Business Unit for Toshiba. “ISMRM’s recognition of Dr. Nakamura’s research further highlights FBI as an effective technique within the scientific community, and strengthens the use of MR technology in this area of medicine.”


Related Content

News | Radiology Business

April 17, 2024 — VISTA.AI announced the appointment of Daniel Hawkins as President and CEO. The company is pioneering AI ...

Time April 17, 2024
arrow
News | Radiology Business

April 4, 2024 — FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Time April 04, 2024
arrow
News | Molecular Imaging

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
News | FDA

March 27, 2024 — SyntheticMR announced that its next-generation imaging solution, SyMRI 3D, has received FDA 510(k) ...

Time March 27, 2024
arrow
News | Artificial Intelligence

March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...

Time March 01, 2024
arrow
News | Cardiac Imaging

February 12, 2024 — According to the American Journal of Roentgenology (AJR), free-breathing cine-deep learning (DL) may ...

Time February 12, 2024
arrow
News | Radiology Business

January 25, 2024 — Esaote Group, a leading Italian innovator in medical imaging, today unveiled its new brand identity ...

Time January 25, 2024
arrow
News | Artificial Intelligence

January 23, 2024 — Quibim announced it has added an industry-leading cancer detection capability to its prostate tool ...

Time January 22, 2024
arrow
News | Artificial Intelligence

December 22, 2023 — Quibim, a company pioneering imaging biomarkers for Precision Medicine that has created AI-based ...

Time December 22, 2023
arrow
News | Magnetic Resonance Imaging (MRI)

December 20, 2023 — Terran Biosciences, Inc., a biotech platform company developing therapeutics and technologies for ...

Time December 20, 2023
arrow
Subscribe Now